{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T21:42:08Z","timestamp":1649194928956},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1097\/01.jaa.0000480579.00874.2c","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T13:11:38Z","timestamp":1461935498000},"page":"60-61","source":"Crossref","is-referenced-by-count":0,"title":["A progressive pruritic rash with blisters"],"prefix":"10.1097","volume":"29","author":[{"given":"Michael D.","family":"Overcash","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matt","family":"Ewald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210130","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.det.2011.03.010","article-title":"Clinical features and practical diagnosis of bullous pemphigoid","volume":"29","author":"Schmidt","year":"2011","journal-title":"Dermatol Clin"},{"key":"R2-11-20210130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/08916934.2011.606447","article-title":"Pemphigoid diseases: pathogenesis, diagnosis, and treatment","volume":"45","author":"Kasperkiewicz","year":"2012","journal-title":"Autoimmunity"},{"key":"R3-11-20210130","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"key":"R4-11-20210130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.tox.2004.12.036","article-title":"Symptoms and danger signs in acute drug hypersensitivity","volume":"209","author":"Bircher","year":"2005","journal-title":"Toxicology"},{"key":"R5-11-20210130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2007.08.036","article-title":"Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel","volume":"58","author":"Halevy","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"R6-11-20210130","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.det.2011.03.004","article-title":"Diagnosis and clinical features of pemphigus vulgaris","volume":"29","author":"Venugopal","year":"2011","journal-title":"Dermatol Clin"},{"key":"R7-11-20210130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J Invest Dermatol"}],"container-title":["Journal of the American Academy of Physician Assistants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000480579.00874.2c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T18:45:45Z","timestamp":1620931545000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01720610-201605000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jaa.0000480579.00874.2c","relation":{},"ISSN":["1547-1896"],"issn-type":[{"value":"1547-1896","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}